NLS Pharmaceutics AG (NLSP) - Balance Sheet Statement

Home
NLSP
Financials

4.15 (USD) • At close November 7, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	0.898	8.948	5.431	0.094	0.22	0.007	2.183
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	0.898	8.948	5.431	0.094	0.22	0.007	2.183
Net Receivables Numbers are in millions	0.011	0.041	0.039	0.061	0.075	0.009	0
Inventory Numbers are in millions	0	-0.041	-0.039	-0.061	0	-0.009	0
Other Current Assets Numbers are in millions	0.915	0.298	0.292	0.103	0.086	0.083	0.091
Total Current Assets Numbers are in millions	1.823	9.246	5.723	0.197	0.382	0.09	2.274
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0.007	0.018	0.03	0	0	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0.068	0.054	0.055	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.017	0.012	0.012	0.947	0.26	0	0.014
Total Non-Current Assets Numbers are in millions	0.024	0.03	0.042	1.015	0.315	0.055	0.014
Total Assets Numbers are in millions	1.847	9.277	5.765	1.212	0.696	0.146	2.288
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	4.634	2.373	1.737	4.006	2.509	1.131	0.565
Short Term Debt Numbers are in millions	1.634	0	-2,499.969	1.771	0.69	0.708	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	2,499.969	2,499.969	-0	0	0
Other Current Liabilities Numbers are in millions	1.652	0.986	0.666	-2,498.543	0.836	0.576	0.425
Total Current Liabilities Numbers are in millions	7.92	3.36	2.403	7.204	4.035	2.415	0.99
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	0	0	0.313	0.152	6.386	8.867
Deferred Revenue Non-Current Numbers are in millions	2.5	2.5	2.5	2.5	2.5	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.261	0.136	0.319	0.178	0.18	0.159	0.148
Total Non-Current Liabilities Numbers are in millions	2.761	2.636	2.819	2.992	2.832	6.545	9.016
Total Liabilities Numbers are in millions	10.68	5.996	5.222	10.196	6.867	8.959	10.006
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0
Common Stock Numbers are in millions	0.733	0.669	0.344	0.145	0.145	0.134	0.128
Retained Earnings Numbers are in millions	-70.373	-58.201	-41.706	-29.76	-26.898	-21.451	-16.304
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.158	-0.051	-0.152	-0.019	-0.019	-0.011	-0.01
Other Total Stockholders Equity Numbers are in millions	60.965	60.865	42.055	20.65	20.601	12.515	8.469
Total Shareholders Equity Numbers are in millions	-8.834	3.281	0.542	-8.984	-6.171	-8.814	-7.717
Total Equity Numbers are in millions	-8.834	3.281	0.542	-8.984	-6.171	-8.814	-7.717
Total Liabilities & Shareholders Equity Numbers are in millions	1.847	9.277	5.765	1.212	0.696	0.146	2.288

NLS Pharmaceutics AG

NASDAQ:NLSP Add to watchlist

NASDAQ:NLSP